Clinical trial
Food-effect Study of Weekly Administration of (bi-)Daily Oral Docetaxel (ModraDoc006) in Combination With Ritonavir
NCT03147378 is registered in ClinicalTrials.gov with Modra Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Food-effect Study of Weekly Administration of (bi-)Daily Oral Docetaxel (ModraDoc006) in Combination With Ritonavir
- Lead sponsor
- Modra Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 10, 2017
- Completion date
- April 4, 2018
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor, adult